Logo image
Sign in
Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial
Journal article   Peer reviewed

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial

G. Lavigne-Lissalde, A.G. Aya, F.J. Mercier, S. Roger-Christoph, C. Chauleur, E. Morau, A.S. Ducloy-Bouthors, A. Mignon, M. Raucoules, A. Bongain, …
Journal of Thrombosis and Haemostasis, Vol.13(4), pp.520 - 529
04/2015
PMID: 25594352

Abstract

FVIIa activated hysterectomy postpartum hemorrhage treatment efficacy treatment outcome
url
Find in HALView

Details

Logo image